REQUEST A DEMO
Total
USD $0.00
Search more companies

Consern Pharma Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Consern Pharma Limited Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Consern Pharma Limited is an unlisted company, incorporated on 17/10/2001. It has its registered office in the State of Punjab, India. Company's corporate identification number (CIN) is U24232PB2001PLC024715 and registration number is 024715. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
308-C, Bhai Randhir Singh Nagar
Ludhiana; Punjab; Postal Code: 141012

Contact Details: Purchase the Consern Pharma Limited report to view the information.

Basic Information
Total Employees:
Purchase the Consern Pharma Limited report to view the information.
Outstanding Shares:
Purchase the Consern Pharma Limited report to view the information.
Registered Capital:
Purchase the Consern Pharma Limited report to view the information.
Incorporation Date:
October 17, 2001
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
54.8%
Purchase this report to view the information.
40.04%
Purchase this report to view the information.
0.16%
Company Performance
Financial values in the chart are available after Consern Pharma Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
17.86%
Total operating revenue
18.11%
Operating profit (EBIT)
46.21%
EBITDA
45.89%
Net Profit (Loss) for the Period
53.13%
Total assets
20.36%
Total equity
52.52%
Operating Profit Margin (ROS)
3.06%
Net Profit Margin
2.76%
Return on Equity (ROE)
0.14%
Debt to Equity Ratio
-17.19%
Quick Ratio
0.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?